Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02556632
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2015-07-23
Brief Title:
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Sponsor:
Gary Morrow
Organization:
University of Rochester
Study Overview
Official Title:
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Curcumin-II
Brief Summary:
This randomized pilot phase II trial studies and compares prophylactic topical agents in reducing radiation-induced dermatitis in patients with non-inflammatory breast cancer or breast cancer in situ The prophylactic topical agents such as curcumin-based gel or HPR Plus may reduce the severity of the radiation-induced dermatitis by minimizing water loss and inflammation during radiation therapy
Detailed Description:
PRIMARY OBJECTIVE
I To investigate the effectiveness of Curcumin gel curcumin-based gel or HPR Plus in reducing radiation dermatitis in breast cancer patients
I To investigate the effectiveness of Curcumin gel curcumin-based gel or HPR Plus in reducing radiation dermatitis in breast cancer patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2015-00869 | REGISTRY | None | None |
| URCC14079 | OTHER | None | None |
| URCC-14079 | OTHER | None | None |
| R21CA178648 | NIH | None | None |
| UG1CA189961 | NIH | DCP | httpsreporternihgovquickSearchUG1CA189961 |